| Training cohort | Validation cohorts (n = 6237) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KCH (n = 1276) | UHS (n = 633) | UCH (n = 411) | GSTT (n = 988) | UHBW (n = 190) | Wuhan (n = 2815) | UHB (n = 1037) | Oslo (n = 163) | |||||||||
COVID-19 WHO Score 6–8 (ICU/death) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) |
 3 days | 1276 | 163 (12.8%) | 633 | 109 (17.2%) | 411 | 120 (29.0%) | 988 | 289 (29.3%) | 190 | 32 (16.8%) | 2815 | 58 (2.1%) | 1037 | 169 (16.3%) | 163 | 27 (16.3%) |
 14 days | 1276 | 389 (30.5%) | 633 | 223 (35.2%) | 411 | 171 (42.0%) | 988 | 391 (39.6%) | 190 | 56 (29.5%) | 2815 | 118 (4.2%) | 1037 | 310 (29.9%) | 163 | 39 (23.9%) |
Demographics | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) |
 Age (median [IQR]) | 1276 | 71.5 [57.1, 82.6] | 633 | 73.0 [56.0, 84.0] | 411 | 66.0 [53.0, 79.0] | 988 | 59.0 [46.0,75.0] | 190 | 73.5 [59.3, 82.0] | 2815 | 60.0 [50.0, 68.0] | 1037 | 70.0 [57.0, 82.0] | 163 | 60.0 [48.0–74.0] |
 Sex (male) | 1276 | 742 (58.2%) | 633 | 364 (57.5%) | 411 | 252 (61.0%) | 988 | 581 (58.8%) | 190 | 120 (63.1%) | 2815 | 1437 (51.0%) | 1037 | 573 (55.3%) | 163 | 95 (58.3%) |
 Non-White ethnicity | 960 | 379 (39.5%) | 546 | 55 (10.0%) | 390 | 156 (40.0%) | 817 | 607 (74.3%) | 190 | 46 (24.2%) | 2815 | 2815 (100.0%) | 892 | 306 (34.3%) | – | – |
Comorbidities | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) | N avail. | N (%) |
 Hypertension | 1276 | 695 (54.5%) | 633 | 321 (50.7%) | 411 | 172 (42.0%) | 988 | 309 (31.3%) | 190 | 117 (61.6%) | 2815 | 821 (29.2%) | 1037 | 637 [61.4%) | 163 | 55 (33.7%) |
 Diabetes mellitus | 1276 | 439 (34.4%) | 633 | 163 (25.8%) | 411 | 105 (26.0%) | 988 | 286 (28.9%) | 190 | 71 (37.4%) | 2815 | 371 (13.2%) | 1037 | 358 (34.5%) | 163 | 27 (16.6%) |
 Heart failure | 1276 | 117 (9.2%) | 633 | 137 (21.6%) | 410 | – | 988 | 52 (5.3%) | 190 | 33 (17.4%) | 2815 | 236 (8.4%)2 | 1037 | 178 (17.2%) | 163 | 15 (9.2%) |
 Ischaemic heart diseases | 1276 | 185 (14.5%) | 633 | 152 (24.0%) | 409 | 108 (26.0%)1 | – | – | 190 | 52 (27.4%) | – | – | 1037 | 245 (23.6%) | 163 | 21 (12.9%) |
 COPD | 1276 | 141 (11.1%) | 633 | 115 (18.2%) | 409 | 27 (6.6%) | 988 | 64 (6.5%) | 190 | 41 (21.6%) | 2815 | 17 (0.6%) | 1037 | 152 (14.7%) | – | – |
 Asthma | 1276 | 174 (13.6%) | 633 | 112 (17.7%) | 409 | 41 (10.0%) | 988 | 85 (8.6%) | 190 | 27 (14.2%) | – | – | 1037 | 169 (16.3%) | – | – |
 Chronic kidney disease | 1276 | 234 (18.3%) | 633 | 111 (17.5%) | 410 | 40 (9.8%) | 988 | 110 (11.1%) | 190 | 59 (31.1%) | 2815 | 56 (2.0%) | 1037 | 274 (26.4%) | 163 | 9 (5.5%) |
Blood biomarker | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] |
 Albumin (g/L) | 1153 | 37.0 [33.0, 40.0] | 501 | 32.0 [29.0, 36.0] | 390 | 38.0 [35.0, 42.0] | 863 | 36.0 [31.0, 40.0] | 190 | 30.0 [27.0, 33.0] | 2404 | 38.1 [35.1, 40.5] | 993 | 32.0 [28.0, 35.0] | 120 | 39.0 [36.0–43.0] |
 C-reactive protein (CRP, mg/L) | 1240 | 80.0 [36.0, 141.6] | 545 | 75.0 [25.0, 150.0] | 403 | 97.0 [45.0, 179.0] | 974 | 76.5 [25.0, 153.8] | 190 | 77.0 [36.3, 138.3] | 2393 | 2.3 [0.8, 9.0] | 970 | 89.0 [33.2, 157.0] | 163 | 48.0 [16.0–113.0] |
 Urea (mmol/L) | 1221 | 7.1 [4.6, 11.7] | 563 | 6.95 [4.8, 10.6] | 375 | 6.0 [4.0, 9.4] | 489 | 7.4 [4.6, 12.5] | – | – | – | – | 1018 | 6.8 [4.6, 11.8] | 154 | 5.5 [4.3–7.5] |
 Estimated GFR | 1254 | 65.0 [41.0, 86.0] | 377 | 62.0 [40.0, 81.0] | 407 | 77.0 [54.0, 96.0] | 965 | 74.0 [49.0, 100.0] | 190 | 68.0 [43.3. 88.0] | 2433 | 103.1 [88.2, 117.5] | 757 | 54.0 [29.0, 72.0] | 163 | 84.0 [57.0–99.0] |
 Haemoglobin (g/L) | 1223 | 127.0 [112.0, 141.0] | 561 | 128.0 [111.0, 143.0] | 410 | 130.0 [112.0, 143.0] | 987 | 125.0 [108.0, 139.0] | 190 | 129.0 [110.0, 141.0] | 2584 | 124.0 [113.0, 135.0] | 1009 | 130.0 [113.0, 144.0] | 163 | 139.0 [129.0–148.0] |
 Lymphocyte count (× 109/L) | 1221 | 0.9 [0.7, 1.3] | 561 | 1.0 [0.7, 1.4] | 410 | 0.9 [0.6, 1.4] | 987 | 0.9 [0.6, 1.3] | 190 | 0.9 [0.6, 1.2] | 2584 | 1.5 [1.1, 1.9] | 1011 | 0.9 [0.7, 1.4] | 153 | 1.1 [0.8–1.5] |
 Neutrophil count (× 109/L) | 1220 | 5.4 [3.8, 7.7] | 560 | 5.8 [4.2, 8.8] | 410 | 5.9 [3.9, 8.2] | 986 | 5.0 [3.5, 8.1] | 190 | 5.2 [3.5, 7.4] | 2584 | 3.5 [2.7, 4.7] | 1011 | 5.5 [3.8, 8.2] | 153 | 4.4 [3.0–7.1] |
 Neutrophil/lymphocyte ratio | 1218 | 5.6 [3.4, 9.5] | 559 | 5.8 [3.4, 10] | 410 | 6.0 [4.0, 10.0] | 986 | 5.6 [3.2, 10.1] | 190 | 5.7 [3.6, 9.8] | 2584 | 2.3 [1.7, 3.5] | 1011 | 5.6 [3.2, 10.2] | 153 | 4.3 [2.4–7.7] |
 Lymphocyte/CRP ratio | 1196 | 1.2 [0.6, 3.2] | 559 | 1.3 [0.5, 4.6] | 402 | 1.0 [0.4, 2.4] |  | 0.0 [0.0, 0.0] | 190 | 1.1 [0.5, 2.7] | 2362 | 0.7 [0.1, 2.0] | 962 | 1.1 [0.5, 3.3] | – | – |
 Platelet count (× 109/L) | 1224 | 213.0 [161.8, 274.0] | 560 | 231 [176.8, 303.5] | 409 | 221.0 [169.0, 280.0] | 986 | 209.0 [161.0, 275.8] | 190 | 207.5 [150.3, 268.5] | 2584 | 223.0 [179.8, 273.0] | 1008 | 218.0 [165.0, 287.2] | 163 | 205.0 [160.0–279.0] |
Physiological parameters | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] | N avail. | Median [IQR] |
 NEWS2 Total Score | 1262 | 2.0 [1.0, 4.0] | 529 | 3.0 [2.0, 5.0] | 404 | 5.0 [3.0, 7.0] | 744 | 3.0 [1.0, 5.0] | 190 | 3.0 [2.0, 5.0] | 2804 | 1.0 [0.0, 3.0] | 1019 | 4.0 [2.0, 7.0] | 163 | 5.0 [3.0–7.0] |
 Heart rate | 1273 | 85.0 [75.0, 94.0] | 560 | 90.5 [82.0, 102.0] | 410 | 94.0 [81.0, 107.0] | 752 | 85.0 [75.0, 95.0] | 190 | 82.0 [71.0, 95.0] | 2812 | 81.0 [76.9, 85.8] | 1028 | 90.0 [79.0, 104.0] | 160 | 89.5 [75.3–100.8] |
 Oxygen saturation | 1273 | 96.0 [95.0, 98.0] | 561 | 97.0 [96.0, 99.0] | 410 | 96.0 [94.0, 98.0] | 712 | 96.0 [95.0, 97.0] | 190 | 95.0 [94.0, 96.0] | 2797 | 97.8 [97.0, 98.2] | 1029 | 96.0 [94.0, 98.0] | 163 | 95.0 [92.0–97.0] |
 Oxygen flow rate (L/min) | 1271 | 0.0 [0.0, 4.0] | 260 | 3.0 [2.0, 8.0] | 403 | 2.0 [0.0, 10.0] | 978 | 0.0 [0.0, 0.0] | 190 | 2.0 [0.0, 3.0] | – | – | 1017 | 0.0 [0.0, 4.0] | 125 | 1.0 [0.0–2.0] |
 Respiration rate | 1273 | 19.0 [18.0, 21.0] | 561 | 20.0 [19.0, 24.0] | 410 | 24.0 [20.0, 28.0] | 755 | 19.0 [18.0, 22.0] | 190 | 20.0 [18.0, 21.0] | 2811 | 20.0 [19.0, 21.0] | 1020 | 20.0 [18.0, 25.0] | 160 | 24.0 [20.0–28.0] |
 Systolic blood pressure | 1273 | 125.0 [112.0, 139.0] | 555 | 137.0 [123.0, 152.0] | 411 | 131.0 [115.0, 143.0] | 751 | 125.0 [115.0, 140.0] | 190 | 123.0 [111.0, 140.8] | 1431 | 120.0 [110.0, 128.0] | 1022 | 128.0 [113.0, 144.0] | 160 | 129 [116.0–142.8] |
 Diastolic blood pressure | 1273 | 71.0 [62.0, 80.0] | 555 | 78.0 [70.0, 85.0] | 411 | 73.0 [64.0, 81.0] | 751 | 74.0 [66.0, 81.0] | 190 | 72.0 [64.3, 82.0] | 1433 | 71.0 [65.0, 78.0] | 1022 | 75.0 [67.0, 84.0] | 160 | 77.0 [69.0–87.0] |
 Temperature | 1273 | 36.9 [36.6, 37.4] | 558 | 36.9 [36.7, 37.5] | 410 | 37.3 [36.8, 38.1] | 750 | 36.9 [36.4, 37.5] | 190 | 37.2 [36.7, 37.9] | 2815 | 36.5 [36.3, 36.7] | 1029 | 36.8 [36.2, 37.5] | 162 | 37.2 [36.5–38.3] |